Stonebridge Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Stonebridge Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-52	Closed	-$5.83K	–	893
2023 Q3	$5.83K	Buy	+52	New	+$6.6K	﹤0.01%	686
2021 Q3	–	Sell	-1,009	Closed	-$157K	–	1126
2021 Q2	$157K	Hold	1,009	–	–	0.01%	292
2021 Q1	$157K	Buy	+1,009	New	+$156K	0.02%	213
2020 Q3	–	Sell	-1,236	Closed	-$143K	–	738
2020 Q2	$143K	Hold	1,236	–	–	0.03%	194
2020 Q1	$121K	Sell	1,236 -155	-11%	-$20.3K	0.03%	192
2019 Q4	$202K	Sell	1,391 -72	-5%	-$9.94K	0.03%	182
2019 Q3	$195K	Sell	1,463 -436	-23%	-$56.3K	0.03%	176
2019 Q2	$217K	Hold	1,899	–	–	0.04%	169
2019 Q1	$235K	Buy	+1,899	New	+$216K	0.04%	163
2018 Q4	–	Sell	-1,827	Closed	-$233K	–	178
2018 Q3	$233K	Buy	+1,827	New	+$217K	0.05%	153
2018 Q1	–	Sell	-1,827	Closed	-$214K	–	185
2017 Q4	$214K	Buy	+1,827	New	+$207K	0.05%	157
2017 Q3	–	Sell	-1,621	Closed	-$202K	–	178
2017 Q2	$202K	Buy	+1,621	New	+$192K	0.05%	146

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonebridge Capital Advisors's ZBH Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 52 shares — an estimated $5.83K sold.

Stonebridge Capital Advisors first reported a position in ZBH in Q2 2017 and held it in 12 quarters. The position peaked at $235K in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 52 Zimmer Biomet shares in Q4 2023, an estimated $5.83K.
Stonebridge Capital Advisors first reported a position in Zimmer Biomet in Q2 2017 and held it in 12 quarters.
Stonebridge Capital Advisors's Zimmer Biomet position peaked at $235K in Q1 2019.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.